EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieKlinische Studie (Phase III)

The Use of Durable Medical Equipment in COURAGE ‐ ALS , a Phase 3, Multicentre, Randomized Clinical Trial for ALS

Stacy A Rudnicki iD, Elisa Giacomelli iD, Katherine Herder iD, Caroline Ingre iD, Stuart Kupfer iD, Fady I Malik iD, Lisa Meng iD, Sabrina Paganoni iD, Kerri Schellenberg iD, Erica Scirocco iD, Tyrell Simkins iD, Jenny Wei iD und 2 weitere

Muscle & Nerve · 2026

DOI: 10.1002/mus.70150 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Stacy A Rudnicki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cytokinetics Incorporated, South San Francisco, California, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Durable Medical Equipment, Noninvasive Ventilation, Wheelchairs. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Cytokinetics, Incorporated, Cytokinetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Durable medical equipment (DME)—wheelchairs, non‐invasive ventilation, gastrostomy tubes, and communication devices—provides vital support for individuals with amyotrophic lateral sclerosis (ALS). Here, we describe DME use in COURAGE‐ALS evaluating reldesemtiv's efficacy and safety in ALS, to evaluate if DME use can be considered an endpoint of interest in ALS trials.

Methods

COURAGE‐ALS, a multicentre, double‐blind, randomized, placebo‐controlled clinical trial was conducted at 83 sites in the United States, Canada, Europe, and Australia. Participants were randomized 2:1 to receive reldesemtiv or placebo for 24 weeks, followed by 24 weeks of active drug treatment. Exploratory outcomes included reasons for prescribing, extent of use, DME types, and regional differences.

Results

Among 482 participants, 166 (34.4%) were using at least one DME item at baseline. Among 276 participants completing study visits through Week 24, 130 (47.1%) initiated use of a total of 188 new DME items post‐baseline through 24 weeks. Manual wheelchairs were most used at baseline (89 items) and initiated (47 items) during the trial. Both baseline DME use and initiating a new item were associated with lower ALS Functional Rating Scale‐Revised scores and worse quality of life. The trial was terminated early due to futility. Treatment assignment did not impact DME use. Regional disparities were noted.

Discussion

This study shows that DME is commonly prescribed to ALS trial participants. Further understanding of geographic differences in DME access and their impact on clinical outcomes is warranted prior to including DME use as an endpoint in ALS trials. Trial Registration: ClinicalTrials.gov identifier: (NCT04944784)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDurable Medical EquipmentNoninvasive VentilationWheelchairsHumansDouble-Blind MethodFemaleMaleAgedMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

amyotrophic lateral sclerosisdurable medical equipmenthealth economics outcomes researchnon‐invasive ventilationreldesemtiv

Autor:innen und Institutionen

  • Cytokinetics Incorporated, South San Francisco, California, USA.
  • Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Karolinska Institute, Stockholm, Sweden.
  • Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • University of Saskatchewan, Saskatoon, Canada.
  • Barrow Neurological Institute and Creighton University, Phoenix, Arizona, USA.

ORCID-Profile: Stacy A Rudnicki, Elisa Giacomelli, Katherine Herder, Caroline Ingre, Stuart Kupfer, Fady I Malik, Lisa Meng, Sabrina Paganoni, Kerri Schellenberg, Erica Scirocco, Tyrell Simkins, Jenny Wei, Jeremy M Shefner

Förderung

  • Cytokinetics, Incorporated
  • Cytokinetics

Zitieren

APA

Rudnicki, S. A., Giacomelli, E., Herder, K., Ingre, C., Kupfer, S., Malik, F. I., Meng, L., Paganoni, S., Schellenberg, K., Scirocco, E., Simkins, T., Wei, J., Shefner, J. M., & COURAGE‐ALS Study Group (2026). The Use of Durable Medical Equipment in COURAGE ‐ ALS , a Phase 3, Multicentre, Randomized Clinical Trial for ALS. Muscle & Nerve. https://doi.org/10.1002/mus.70150

Vancouver

Rudnicki SA, Giacomelli E, Herder K, Ingre C, Kupfer S, Malik FI, et al. The Use of Durable Medical Equipment in COURAGE ‐ ALS , a Phase 3, Multicentre, Randomized Clinical Trial for ALS. Muscle & Nerve. 2026. doi:10.1002/mus.70150

BibTeX
@article{Rudnicki2026,
  author = {Rudnicki, Stacy A and Giacomelli, Elisa and Herder, Katherine and Ingre, Caroline and Kupfer, Stuart and Malik, Fady I and Meng, Lisa and Paganoni, Sabrina and Schellenberg, Kerri and Scirocco, Erica and Simkins, Tyrell and Wei, Jenny and Shefner, Jeremy M and COURAGE‐ALS Study Group, COURAGE‐ALS Study Group},
  title = {The Use of Durable Medical Equipment in COURAGE ‐ ALS , a Phase 3, Multicentre, Randomized Clinical Trial for ALS},
  journal = {Muscle & Nerve},
  year = {2026},
  doi = {10.1002/mus.70150}
}
Kostenlos starten →